RadMD helps sponsors plan and execute the imaging components of clinical trials, from protocol design and site qualification through image collection, reader training, and blinded independent central review. Its teams advise on modality selection, acquisition standards, imaging charters, endpoint definitions, and regulatory expectations. Centralized quality control and experienced readers reduce variability across sites and provide defensible imaging data for oncology and other therapeutic programs.
RadMD Imaging
RadMD is a highly specialized imaging consulting firm and imaging core lab providing expertise for clinical trials across the pharmaceutical, biotech, and medical device sectors. By training clinical trial readers and offering blinded independent central reviews (BICR), RadMD ensures standardized, regulatory-compliant imaging endpoint evaluation that de-risks drug approval pathways.
